(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 5g

tert-butyl 4-(7-(2-(cyclopropylmethoxy)-6-((4-methoxybenzyl)oxy)phenyl)-2-oxo-2,4-dihydro-1H-pyrido[2,3-d][1,3]oxazin-5-yl)piperidine-1-carboxylate, 97%, 25mg

Triphenylmethylsilane, 97%, 100g

(2E)-3-[4-(benzyloxy)phenyl]-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

2,2-Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)acetonitrile, 97%, 100mg

2,6-Dichloropyrazine>99.0%(GC)5g

(S)-N-Cbz-3-Hydroxypyrrolidine, 95.0%, 100g

5-Amino-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-4-carboxamide, 95.0%, 1g

2,4-Dimethylthiazole, 97.0%, 1g

Ethyl 5-quinolinecarboxylate, 95.0%, 5g

1-Benzylpiperidine-4-carboxylic acid ethyl ester, 99.0%, 100g

2-Bromo-4,5-dichlorobenzenamine, 98%, 500mg

Nonadecanedioic acid, 97%, 250mg